In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea?

BACKGROUND: Lack of effective treatment of gonorrhoea due to increasing antimicrobial resistance in Neisseria gonorrhoeae is a serious threat to the management and control of the infection. Novel antimicrobials are required to prevent the infection becoming untreatable. OBJECTIVES: Herein, we invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobsson, Susanne, Mason, Clive, Khan, Nawaz, Meo, Paul, Unemo, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524478/
https://www.ncbi.nlm.nih.gov/pubmed/30778550
http://dx.doi.org/10.1093/jac/dkz060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524478/
https://www.ncbi.nlm.nih.gov/pubmed/30778550
http://dx.doi.org/10.1093/jac/dkz060

Ejemplares similares